Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05142605 · ClinicalTrials.gov registry record · NA

Evaluation of Grief Therapy Approaches for Bereaved Parents

A NA study of Cancer and Grief, sponsored by University of Miami.

Recruiting
Registry status
NA
Development phase
415
Enrollment target
4
Study locations

NCT05142605: Recruiting NA study of Cancer and Grief, sponsored by University of Miami.

NCT05142605 is a NA study of Cancer and Grief that is actively recruiting participants, run by University of Miami. The registered enrollment target is 415 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (88% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05142605, a NA study of Cancer and Grief, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
NA
Development phase
415 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to compare three types of support programs for parents who have lost a child. The study will see how these support programs affect participants' grief and depression symptoms. The three support programs are called Meaning-Centered Grief Therapy, Supportive Counseling, and Enhanced Usual Care.

Primary Outcome

The Prolonged Grief-13-Revised (PG-13-R) is a 13-item self-report scale evaluating the proposed symptoms of prolonged grief disorder. The PG-13-R assesses the severity of 10 grief-related symptoms using a 5-point Likert-type scale. Additional items evaluate the experience of a significant loss, symptom duration, and functional impairment. The PG-13-R yields a score between 10 and 50, where a higher score indicates that a person experiences higher levels of prolonged grief.

Interventions

  • BEHAVIORAL Enhanced Usual Care
  • BEHAVIORAL Meaning-Centered Grief Therapy
  • BEHAVIORAL Supportive Psychotherapy

Study Locations (4)

Florida

  • University of Miami - Miami

New York

  • Memorial Sloan Kettering Cancer Center - New York

Pennsylvania

  • Children's Hospital of Philadelphia (Data Collection Only) - Philadelphia

Tennessee

  • St Jude's Children's Hospital (Data collection only) - Memphis

Trial Details

FieldValue
Enrollment Target 415 participants
Start Date 2022-03-31
Est. Completion 2026-05-31
Phase NA
University of Miami

721 total trials

What NCT05142605 shows while recruiting

NCT05142605 is an interventional study that assigns participants to a tested intervention. The registered 415 participants enrollment target is mid-sized for trials with a published cap, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (88% lower).

The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 3 interventions - of which Enhanced Usual Care is the first listed.

NCT05142605 reports a single indexed study location in Florida, New York, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05142605 about?

NCT05142605 is a clinical study titled "Evaluation of Grief Therapy Approaches for Bereaved Parents". The purpose of this study is to compare three types of support programs for parents who have lost a child. The study will see how these support programs affect participants' grief and depression symptoms. The three support programs are called Meaning-Centered Grief Therapy, Supportive Counseling, an...

What is the current status of trial NCT05142605?

This trial is currently recruiting. It is a NA study. The enrollment target is 415 participants. The study started on 2022-03-31. Estimated completion is 2026-05-31.

What conditions does trial NCT05142605 study?

This clinical trial studies the following conditions: Cancer, Grief, Bereavement.

What interventions are being tested in trial NCT05142605?

The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), Meaning-Centered Grief Therapy (BEHAVIORAL), Supportive Psychotherapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT05142605?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05142605 being conducted?

This trial has 4 study locations across Florida, New York, Pennsylvania, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05142605's enrollment target sits among peer trials

415 145th of 615 higher than 471 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03527537 · 416 participants · Phase 4

    Gestational Diabetes and Pharmacotherapy (GAP)

  • NCT05007782 · 416 participants · Phase 1

    Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors

  • NCT06075745 · 416 participants · Phase 2

    Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates

  • NCT06111040 · 416 participants · NA

    Nurturing Needs Study: Parenting Food Motivated Children

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05142605, the US trial registry maintained by the National Library of Medicine. NCT05142605 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.